NASDAQ NMS - GLOBAL MARKET · CERS

-1.94% · -$0.0400 · Vol 1.2M

Live · updated 15:35:49 ET

Cerus Corp

Health Care

$2.27

Card

Relationship Map

Follow $CERS

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CERS by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measured

Stale score · Tue Sep 29 · completed session · 2d 21h old · Scheduled each trading day · CERS

Methodology

Thu Oct 1 snapshot unavailable for CERS. Cause unavailable.

Sentiment absence reason unknown

CERS

Cerus Corp

Stale score · Tue Sep 29 · completed session · 2d 21h old · Scheduled each trading day

73/100

Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

73/ 100

Veridion Score

Upper range · MEDIUM confidence · 5 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: MEDIUM · 5 of 6 factors measured · Stale score · Tue Sep 29 · completed session · 2d 21h old · Scheduled each trading day

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is CERS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move CERS next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Sep 29
Score
Score moved -4
77/Highest qualified -> 73/Upper range
Veridion score historySource

About Cerus Corp

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Listed since

1997

Employees

345

Country

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$2.35

Day high

$2.37

Day low

$2.26

Previous close

$2.32

52W high

$3.28

-30.64% from high

52W low

$1.40

47% of range

Market cap

$467.5M

EPS

$-0.0800

Beta

0.62

Shares out

201.5M

Volume

1.2M

0.71× rel vol

Avg volume

1.7M

VWAP

$2.31

Price history computed in-house

-13.17%

-12.50%

-28.01%

+50.66%

YTD

+10.44%

SMA 50 $2.62 · below

SMA 200 $2.43 · below

52W position 47%

CERS overview

Veridion Score

Registered · 2026-09-29

5 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around CERS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

CERS insider activity

Cerus Corp

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in CERS

Congress tracker Open ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CERS in the cached public ledger.

Federal contracts

CERS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for CERS in this window.

Lobbying spend

CERS lobbying filings, year to date.

Registered lobbying filings matched to Cerus Corp.

$120.0K

Refresh interval: 12hSource: LDA disclosure filings

Budget/Appropriations Defense Health IssuesHealth Issues Budget/Appropriations Defense

Filing

$40.0K

CERUS CORPORATION

INNOVATIVE FEDERAL STRATEGIES, LLC

Jul 20, 2026

Filing

$40.0K

CERUS CORPORATION

INNOVATIVE FEDERAL STRATEGIES, LLC

Apr 20, 2026

Filing

$40.0K

CERUS CORPORATION

INNOVATIVE FEDERAL STRATEGIES, LLC

Jan 20, 2026

Analyst ratings

Sovereign unlock shows live analyst consensus for CERS.

Options

Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Follow $CERS

Why is CERS moving today?

What can move CERS next.

CERS overview

Related filings and maps

CERS insider activity

CERS contract awards, year to date.

CERS lobbying filings, year to date.

Cross-references from this score page.

What can move CERS next.

CERS insider activity

Cross-references from this score page.